The pathogenesis of multiple sclerosis: is it really a primary inflammatory process?MAGGS, F. G; PALACE, J.Multiple sclerosis. 2004, Vol 10, Num 3, pp 326-329, issn 1352-4585, 4 p.Article

New treatments and azathioprine in multiple sclerosisPALACE, J; ROTHWELL, P.Lancet (British edition). 1997, Vol 350, Num 9073, issn 0140-6736, 261Article

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7LASHLEY, D; PALACE, J; JAYAWANT, S et al.Neurology. 2010, Vol 74, Num 19, pp 1517-1523, issn 0028-3878, 7 p.Article

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis opticaVIEGAS, S; WEIR, A; ESIRI, M et al.Journal of neurology, neurosurgery and psychiatry. 2009, Vol 80, Num 6, pp 679-682, issn 0022-3050, 4 p.Article

Beta-interferon treatment does not always slow the progression of axonal injury in multiple sclerosisPARRY, A; CORKILL, R; BLAMIRE, A. M et al.Journal of neurology. 2003, Vol 250, Num 2, pp 171-178, issn 0340-5354, 8 p.Article

The effect of anti-α4 integrin antibody on brain lesion activity in MSTUBRIDY, N; BEHAN, P. O; YOUNG, C et al.Neurology. 1999, Vol 53, Num 3, pp 466-472, issn 0028-3878Article

Memory in myasthenia gravis : Neuropsychological tests of central cholinergic function before and after effective immunologic treatmentGLENNERSTER, A; PALACE, J; WARBURTON, D et al.Neurology. 1996, Vol 46, Num 4, pp 1138-1142, issn 0028-3878Article

APOE epsilon variation in multiple sclerosis susceptibility and disease severity : Some answersBURWICK, R. M; RAMSAY, P. P; SAVETTIERI, G et al.Neurology. 2006, Vol 66, Num 9, pp 1373-1383, issn 0028-3878, 11 p.Article

Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitisWATSON, R; JIANG, Y; HART, Y et al.Neurology. 2004, Vol 63, Num 1, pp 43-50, issn 0028-3878, 8 p.Article

Rapsyn mutations in hereditary myasthenia: Distinct early- and late-onset phenotypesBURKE, G; COSSINS, J; BEESON, D et al.Neurology. 2003, Vol 61, Num 6, pp 826-828, issn 0028-3878, 3 p.Article

Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosisEVANGELOU, N; KONZ, D; ESIRI, M. M et al.Brain. 2001, Vol 124, pp 1813-1820, issn 0006-8950, 9Article

Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosisEVANGELOU, N; KONZ, D; ESIRI, M. M et al.Brain. 2000, Vol 123, pp 1845-1849, issn 0006-8950, 9Article

Influence of pregnancy on neuromyelitis optica spectrum disorderKIM, W; KIM, S.-H; SILVA, A. M et al.Neurology. 2012, Vol 78, Num 16, pp 1264-1267, issn 0028-3878, 4 p.Article

Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patientsLEITE, M. I; COUTINHO, E; VILLA, A. M et al.Neurology. 2012, Vol 78, Num 20, pp 1601-1607, issn 0028-3878, 7 p.Article

Neuroprotection and repairPALACE, J.Journal of the neurological sciences. 2008, Vol 265, Num 1-2, pp 21-25, issn 0022-510X, 5 p.Conference Paper

Neocortical neuronal, synaptic, and glial loss in multiple sclerosisWEGNER, C; ESIRI, M. M; CHANCE, S. A et al.Neurology. 2006, Vol 67, Num 6, pp 960-967, issn 0028-3878, 8 p.Article

A sensitive radioimmunoprecipitation assay for assessing the clinical relevance of antibodies to IFN βLAWRENCE, N; OGER, J; AZIZ, T et al.Journal of neurology, neurosurgery and psychiatry. 2003, Vol 74, Num 9, pp 1236-1239, issn 0022-3050, 4 p.Article

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis : A longitudinal clinical and MRI studyLEE, M. A; PALACE, J; STABLER, G et al.Brain. 1999, Vol 122, pp 191-197, issn 0006-8950, 2Article

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onsetCOLLONGUES, N; MARIGNIER, R; PAPEIX, C et al.Multiple sclerosis. 2014, Vol 20, Num 8, pp 1086-1094, issn 1352-4585, 9 p.Article

MRI criteria for MS in patients with clinically isolated syndromesMONTALBAN, X; TINTORE, M; ROVARIS, M et al.Neurology. 2010, Vol 74, Num 5, pp 427-434, issn 0028-3878, 8 p.Article

MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findingsSEEWANN, A; ENZINGER, C; TINTORE, M et al.Journal of neurology. 2008, Vol 255, Num 1, pp 1-10, issn 0340-5354, 10 p.Article

Inflammation versus neurodegeneration : Consequences for treatmentPALACE, J.Journal of the neurological sciences. 2007, Vol 259, Num 1-2, pp 46-49, issn 0022-510X, 4 p.Conference Paper

Intravenous immunoglobulin in neurological disease: a specialist reviewWILES, C. M; BROWN, P; ROSE, M. R et al.Journal of neurology, neurosurgery and psychiatry. 2002, Vol 72, Num 4, pp 440-448, issn 0022-3050Article

A radioimmunoprecipitation assay for antibodies to botulinum APALACE, J; NAIRNE, A; HYMAN, N et al.Neurology. 1998, Vol 50, Num 5, pp 1463-1466, issn 0028-3878Article

Defining multiple sclerosis disease activity using MRI T₂-weighted difference imagingLEE, M. A; SMITH, S; PALACE, J et al.Brain. 1998, Vol 121, pp 2095-2102, issn 0006-8950, 11Article